Reports for IRBESARTAN
Ingredient
IRBESARTAN
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
PMS-IRBESARTAN | 75MG | TABLET | Resolved | 2023-08-10 | 2023-08-28 | 201548 |
SANDOZ IRBESARTAN HCT | 25MG 300MG | TABLET | Resolved | 2023-09-19 | 2024-01-09 | 204738 |
PMS-IRBESARTAN-HCTZ | 25MG 300MG | TABLET | Resolved | 2023-10-02 | 2023-12-22 | 205611 |
SANDOZ IRBESARTAN | 75MG | TABLET | Resolved | 2023-10-02 | 2024-02-01 | 205797 |
TEVA-IRBESARTAN | 150MG | TABLET | Resolved | 2023-10-05 | 2023-11-03 | 206422 |
SANDOZ IRBESARTAN | 150MG | TABLET | Resolved | 2023-10-23 | 2023-10-31 | 207764 |
IRBESARTAN | 300MG | TABLET | Resolved | 2023-10-23 | 2024-02-29 | 207903 |
TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Resolved | 2023-11-03 | 2024-03-07 | 209122 |
SANDOZ IRBESARTAN HCT | 12.5MG 150MG | TABLET | Resolved | 2023-11-06 | 2023-12-12 | 209216 |
IRBESARTAN | 75MG | TABLET | Resolved | 2023-11-22 | 2024-04-01 | 211146 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-IRBESARTAN | 300MG | TABLET | Discontinued | 2017-08-24 | 2017-10-03 | 20271 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
MYLAN-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-04-04 | 2018-08-11 | 44867 |
MYLAN-IRBESARTAN | 75MG | TABLET | Discontinued | 2018-04-04 | 2018-08-01 | 44870 |
VAN-IRBESARTAN | 75MG | TABLET | Discontinued | 2018-08-17 | 2018-08-17 | 58386 |
VAN-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-08-17 | 2018-08-17 | 58389 |